VEON Granted Extension by Nasdaq for 20-F Filing

VEON had previously reported that it would be delayed in its filing of its 2023 20-F due to extraordinary circumstances related to the war in Ukraine and the sale of its Russian operations which impacted its ability to appoint an independent Public Company Accounting Oversight Board ("PCAOB") registered audit firm; and announced that it had received notice from Nasdaq that it was not in compliance with the timely filing requirements for continued listing under Nasdaq Listing Rule 5250(c)(1). Since that time ...